1.
Prussick R, Lebwohl M, Gunn N, Harris S, Vittitow J, Jacobson A, Israel RJ. Patients With Psoriasis Treated With Brodalumab: A Pooled Post Hoc Analysis of a Marker of Liver Inflammation in Individuals With Potential Indicators of Early Nonalcoholic Fatty Liver Disease. J of Skin [Internet]. 2019Nov.9 [cited 2022Aug.20];3:S20. Available from: https://www.jofskin.org/index.php/skin/article/view/747